Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
Is a |
flydende antacidum |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antacid (substance) |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
Has manufactured dose form |
Oral suspension |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
Is a |
Product containing potassium bicarbonate and sodium alginate (medicinal product) |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Potassium bicarbonate |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Potassium electrolyte |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sodium alginate |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Potassium |
false |
Inferred relationship |
Some |
|
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|